Christopher Richard Anzalone insider trades

Open-market stock purchases and sales by Christopher Richard Anzalone, Chief Executive Officer at Arrowhead Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 4, 2010.

Recent trades

DateStockTradeValue
Jan 2, 2026ARWR Arrowhead Pharmaceuticals, IncSold$489K
Jan 2, 2026ARWR Arrowhead Pharmaceuticals, IncSold$383K
Dec 29, 2025ARWR Arrowhead Pharmaceuticals, IncSold$2.4M
Dec 29, 2025ARWR Arrowhead Pharmaceuticals, IncSold$1.1M
Dec 29, 2025ARWR Arrowhead Pharmaceuticals, IncBought (not open market)—
Dec 29, 2025ARWR Arrowhead Pharmaceuticals, IncBought (not open market)—
Dec 22, 2025ARWR Arrowhead Pharmaceuticals, IncSold$684K
Dec 22, 2025ARWR Arrowhead Pharmaceuticals, IncSold$177K
Dec 19, 2025ARWR Arrowhead Pharmaceuticals, IncSold$265K
Dec 19, 2025ARWR Arrowhead Pharmaceuticals, IncSold$554K
Dec 19, 2025ARWR Arrowhead Pharmaceuticals, IncSold$90.3K
Dec 17, 2025ARWR Arrowhead Pharmaceuticals, IncSold$2.9M
Dec 17, 2025ARWR Arrowhead Pharmaceuticals, IncSold$2.3M
Dec 17, 2025ARWR Arrowhead Pharmaceuticals, IncSold$64.4K
Dec 17, 2025ARWR Arrowhead Pharmaceuticals, IncSold$131K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$509K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$671K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$876K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$533K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$428K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$65K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$85.5K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$11.1K
Dec 16, 2025ARWR Arrowhead Pharmaceuticals, IncSold$219K
Dec 15, 2025ARWR Arrowhead Pharmaceuticals, IncSold$6.9M

Companies traded

  • ARWR Arrowhead Pharmaceuticals, Inc: 4 buys, 106 sales, last Jan 2, 2026

Get free alerts when Christopher Richard Anzalone files a new trade →